Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk

被引：0
|
作者：
Yadong Wang
Haiyan Yang
Haiyu Wang
机构：
[1] Henan Center for Disease Control and Prevention,Department of Toxicology
[2] Zhengzhou University,Department of Epidemiology, School of Public Health
来源：
Breast Cancer Research and Treatment | 2015年 / 150卷
关键词：
Polymorphism; Breast cancer; Risk; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
With great interest, we read the recent article entitled “Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis” published online in Pabalan et al. (Breast Cancer Res Treat 137:553–558, 2013). This article suggests that overall summary estimates imply no associations but suggest susceptibility among carriers of the C47G polymorphism and Pro-Ser genotype in premenopausal women. The result is encouraging. Nevertheless, several key issues in this meta-analysis are worth noticing.
引用
收藏
页码：467 / 471
页数：4
相关论文
共 50 条
  • [41] Note of clarification regarding data about the association between the interleukin-1β-31T>C polymorphism and breast cancer risk
    Wang, Yadong
    Wang, Yan
    Li, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 415 - 417
  • [42] Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
    Szilvia Solyom
    Katri Pylkäs
    Robert Winqvist
    Familial Cancer, 2010, 9 : 537 - 540
  • [43] Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations
    Badve, Shivani B.
    Kim, Emily
    Sibia, Udai S.
    Borrego, Orestes T.
    Vara, Stephen
    Damron, Alexander
    Riker, Adam I.
    OCHSNER JOURNAL, 2024, 24 (02): : 157 - 161
  • [44] BRIP1/FANCJ Mutation Analysis in a Family with History of Male and Female Breast Cancer in India
    Venkateshwari, Ananthapur
    Clark, David Wayne
    Nallari, Pratibha
    Vinod, Cingeetham
    Kumarasamy, Thangaraj
    Reddy, Goverdhan
    Jyothy, Akka
    Kumar, Malladi Vijay
    Ramaiyer, Raghuraman
    Palle, Komaraiah
    JOURNAL OF BREAST CANCER, 2017, 20 (01) : 104 - 107
  • [45] The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort
    Zhang, Haiping
    Qian, Haisheng
    Tao, Bilin
    Yang, Miaomiao
    Gong, Jingye
    Yi, Honggang
    Tang, Shaowen
    INFECTION GENETICS AND EVOLUTION, 2018, 66 : 217 - 221
  • [46] MUTATION ANALYSIS FOR BRIP1 IN KOREAN PATIENTS WITH BRCA1/2 MUTATIONS-NEGATIVE HIGH-RISK BREAST CANCER
    Kim, H.
    Cho, D.
    Choi, D. H.
    Park, W.
    Huh, S. J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
    Gupta, Ishita
    Ouhtit, Allal
    Al-Ajmi, Adil
    Rizvi, Syed Gauhar A.
    Al-Riyami, Hamad
    Al-Riyami, Marwa
    Tamimi, Yahya
    ENDOCRINE CONNECTIONS, 2018, 7 (01): : 65 - 77
  • [48] Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer
    Velazquez, Carolina
    Esteban-Cardenosa, Eva M.
    Lastra, Enrique
    Abella, Luis E.
    de la Cruz, Virginia
    Lobaton, Carmen D.
    Duran, Mercedes
    Infante, Mar
    MOLECULAR CARCINOGENESIS, 2019, 58 (01) : 156 - 160
  • [49] Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families
    Solyom, S.
    Pylkas, K.
    Winqvist, R.
    EJC SUPPLEMENTS, 2010, 8 (05): : 14 - 14
  • [50] Mutation analysis for BRIP1 in Korean patients with BRCA1/2 mutations-negative high-risk breast cancer
    Kim, H.
    Cho, D. Y.
    Choi, D. H.
    Park, W.
    Huh, S. J.
    Lee, M. H.
    Ahn, S. H.
    Son, B. H.
    Kim, S. W.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S62 - S62
12345